ELEV insider filings
Elevation Oncology, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-07-24. Screen ELEV transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ELEV between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Elevation Oncology, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-07-24 | 4 | Sandler Alan B. — Director | Disposition to issuer (D): 55,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 | EDGAR |
| 2025-07-24 | 4 | Mootz Darcy — Director | Disposition to issuer (D): 55,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 | EDGAR |
| 2025-07-24 | 4 | Furlong Tammy — CHIEF FINANCIAL OFFICER | Code (U): 37,957 @ $0.36 · Disposition to issuer (D): 79,327 (derivative) @ $0 · Disposition to issuer (D): 79,327 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 · Disposition to issuer (D): 52,500 (derivative) @ $0 · Disposition to issuer (D): 28,800 (derivative) @ $0 · +3 more | EDGAR |
| 2025-07-24 | 4 | Cherrington Julie M — Director | Disposition to issuer (D): 55,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 | EDGAR |
| 2025-07-24 | 4 | Carruthers R Michael — Director | Disposition to issuer (D): 47,330 (derivative) @ $0 · Disposition to issuer (D): 15,619 (derivative) @ $0 · Disposition to issuer (D): 31,238 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 | EDGAR |
| 2025-07-24 | 4 | ELMS STEVE — Director | Disposition to issuer (D): 31,238 (derivative) @ $0 · Disposition to issuer (D): 15,619 (derivative) @ $0 · Disposition to issuer (D): 31,238 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 | EDGAR |
| 2025-07-24 | 4 | CLACKSON TIMOTHY P — Director | Code (U): 47,330 @ $0.36 · Disposition to issuer (D): 15,619 (derivative) @ $0 · Disposition to issuer (D): 31,238 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Ferra Joseph J Jr — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 12,560 · Tax withholding (F): 4,627 @ $0.39 · Option exercise (M): 12,560 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Sandler Alan B. — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Mootz Darcy — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Cherrington Julie M — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Carruthers R Michael — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | ELMS STEVE — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | CLACKSON TIMOTHY P — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Furlong Tammy — CHIEF FINANCIAL OFFICER | Option exercise (M): 2,643 · Tax withholding (F): 784 @ $0.30 · Option exercise (M): 2,343 (derivative) @ $0 · Option exercise (M): 300 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Ferra Joseph J Jr — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 6,250 · Tax withholding (F): 2,303 @ $0.30 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Ferra Joseph J Jr — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 12,562 · Tax withholding (F): 4,628 @ $0.53 · Option exercise (M): 12,562 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Jansen Valerie Malyvanh — CHIEF MEDICAL OFFICER | Option exercise (M): 17,500 · Tax withholding (F): 5,189 @ $0.67 · Grant/award (A): 275,000 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Furlong Tammy — CHIEF FINANCIAL OFFICER | Option exercise (M): 9,375 · Tax withholding (F): 2,780 @ $0.67 · Option exercise (M): 300 · Tax withholding (F): 89 @ $0.67 · Grant/award (A): 275,000 (derivative) @ $0 · Option exercise (M): 9,375 (derivative) @ $0 · +1 more | EDGAR |
| 2025-02-19 | 4 | Dornan David — CHIEF SCIENTIFIC OFFICER | Option exercise (M): 9,375 · Tax withholding (F): 4,152 @ $0.67 · Option exercise (M): 9,375 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Ferra Joseph J Jr — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 25,000 · Tax withholding (F): 9,211 @ $0.67 · Grant/award (A): 800,000 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | Ferra Joseph J Jr — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 12,563 · Tax withholding (F): 4,629 @ $0.64 · Option exercise (M): 12,563 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | Furlong Tammy — CHIEF FINANCIAL OFFICER | Option exercise (M): 300 · Tax withholding (F): 98 @ $0.53 · Option exercise (M): 300 (derivative) @ $0 | EDGAR |
| 2024-09-18 | 4 | Ferra Joseph J Jr — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 12,562 · Tax withholding (F): 4,628 @ $0.61 · Option exercise (M): 12,562 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | Furlong Tammy — CHIEF FINANCIAL OFFICER | Option exercise (M): 300 · Tax withholding (F): 89 @ $0.72 · Option exercise (M): 300 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Ferra Joseph J Jr — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 12,562 · Tax withholding (F): 4,628 @ $3.23 · Option exercise (M): 12,562 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Sandler Alan B. — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Mootz Darcy — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Cherrington Julie M — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Carruthers R Michael — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | ELMS STEVE — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | CLACKSON TIMOTHY P — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Furlong Tammy — CHIEF FINANCIAL OFFICER | Option exercise (M): 300 · Tax withholding (F): 100 @ $3.73 · Option exercise (M): 300 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | Ferra Joseph J Jr — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 12,562 · Tax withholding (F): 4,773 @ $4.39 · Option exercise (M): 12,562 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Sandler Alan B. — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Cherrington Julie M — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2024-02-20 | 4 | Jansen Valerie Malyvanh — CHIEF MEDICAL OFFICER | Grant/award (A): 225,000 (derivative) @ $0 · Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2024-02-20 | 4 | Furlong Tammy — CHIEF FINANCIAL OFFICER | Option exercise (M): 1,200 · Tax withholding (F): 403 @ $2.77 · Grant/award (A): 225,000 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Option exercise (M): 1,200 (derivative) @ $0 | EDGAR |
| 2024-02-20 | 4 | Dornan David — CHIEF SCIENTIFIC OFFICER | Grant/award (A): 225,000 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2024-02-20 | 4 | Ferra Joseph J Jr — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 600,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-01-22 | 4 | Mootz Darcy — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2023-12-19 | 4 | Ferra Joseph J Jr — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 12,563 · Tax withholding (F): 4,773 @ $0.51 · Option exercise (M): 12,563 (derivative) @ $0 | EDGAR |
| 2023-09-19 | 4 | Ferra Joseph J Jr — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 12,562 · Tax withholding (F): 4,773 @ $0.73 · Option exercise (M): 12,562 (derivative) @ $0 | EDGAR |
| 2023-09-05 | 4 | CLACKSON TIMOTHY P — Director | Gift (G): 15,777 @ $0 | EDGAR |
| 2023-07-14 | 4 | Furlong Tammy — CHIEF FINANCIAL OFFICER | Grant/award (A): 53,433 (derivative) @ $0 | EDGAR |
| 2023-07-14 | 4 | Ferra Joseph J Jr — CHIEF EXECUTIVE OFFICER | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | Ferra Joseph J Jr — INTERIM CEO & CFO | Option exercise (M): 12,563 · Tax withholding (F): 4,773 @ $1.47 · Option exercise (M): 12,563 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | Carruthers R Michael — Director | Grant/award (A): 31,238 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | CLACKSON TIMOTHY P — Director | Grant/award (A): 31,238 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | Aisling Capital IV, LP — 10% owner Aisling Capital Partners IV LLC — 10% owner Aisling Capital Partners IV, LP — 10% owner ELMS STEVE — 10% owner SCHIFF ANDREW N — 10% owner | Grant/award (A): 31,238 (derivative) @ $0 | EDGAR |
Recent 8-K events — Elevation Oncology, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-07-23 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-02 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2025-06-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-05 | 8-K | 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement | EDGAR |
| 2025-04-04 | 8-K | 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement | EDGAR |
| 2025-04-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-03-20 | 8-K | ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-19 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-03-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ELEV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →